Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Haoting Chen

1PUBLICATIONS

10CO-AUTHORS

Molecular targets

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (1)

Sort by Publication Date:

|Mar 27, 2021

Exploiting the acquired vulnerability of cisplatin-resistant tumors with a hypoxia-amplifying DNA repair-inhibiting (HYDRI) nanomedicine.

Jing Chen, Xue Wang, Yuan Yuan

Pageof 1

Frequent Collaborators

1 joint publications

Jing Chen

1 joint publications

Xue Wang

1 joint publications

Yuan Yuan

1 joint publications

Lingpu Zhang

1 joint publications

Haihua Xiao

1 joint publications

Jingqi Chen

1 joint publications

Yongxiang Zhao

1 joint publications

Jin Chang

1 joint publications

Weisheng Guo

1 joint publications

Xing-Jie Liang

Frequent Collaborators

1 joint publications

Jing Chen

1 joint publications

Xue Wang

1 joint publications

Yuan Yuan

1 joint publications

Lingpu Zhang

Top Related Videos

Evaluating the Effectiveness of Cancer Drug Sensitization <em>In Vitro</em> and <em>In Vivo</em>

Evaluating the Effectiveness of Cancer Drug Sensitization <em>In Vitro</em> and <em>In Vivo</em>

Published on : Feb 06, 2015

See more related videos

Top Related Videos

Evaluating the Effectiveness of Cancer Drug Sensitization <em>In Vitro</em> and <em>In Vivo</em>

Evaluating the Effectiveness of Cancer Drug Sensitization <em>In Vitro</em> and <em>In Vivo</em>

Published on : Feb 06, 2015

See more related videos